Faeth Therapeutics, Inc.
Research Faeth Therapeutics, Inc. (FTH) on Bullrun: market cap USD 569.62M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFTH
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 569.62M
- Financial periodQ3 2026
- RevenueUSD 0
- Net income-USD 20.40M
- Free cash flow-USD 13.01M
Valuation Snapshot
latest market cap is USD 569.62M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 21.09M | -USD 20.47M | n/a | -16.72 | USD 8.67M | USD 1.51M | USD 18.59M |
| FY2024 | USD 0 | -USD 30.16M | -USD 24.82M | n/a | -24 | USD 9.99M | USD 3.85M | USD 38.39M |
| FY2023 | USD 0 | -USD 34.10M | -USD 32.20M | n/a | -24.4 | USD 13.01M | USD 6.21M | USD 64.90M |
| FY2022 | USD 0 | -USD 48.59M | -USD 39.35M | n/a | -31.6 | USD 17.80M | USD 8.03M | USD 103.41M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-06 | USD 569.62M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 13.46M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 12.34M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 345.95M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 915.48M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 3.55B | n/a | n/a | n/a |
About Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Faeth Therapeutics, Inc.'s market cap?
Faeth Therapeutics, Inc.'s market capitalization is USD 569.62M.
What does Faeth Therapeutics, Inc. do?
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors.